The results highlighted PYGB as a potential therapeutic target for U87MG of GBM and indicated that 2,3-benzodiazepin-4-one can be used to develop anti-cancer drugs for glioblastoma because it can negatively regulate glucose uptake and metabolism (the “Warburg effect”) [63]. The gene discussed is PYGB; the disease is cancer.